Voronoi IPO Preview
Voronoi has developed a genotype-directed therapy that is effective for tumors caused by mutations in kinases, and has successfully conducted...
242 Views
Icure Pharm (175250 KS): High Hope for Transdermal Patch-Type Dementia Treatment Option
Icure received approval for world’s first donepezil patch for the treatment of dementia. The company estimates the patch will be over KRW 1...
464 Views
KOSPI Lockup Releases - Boryung Pharm, CJ CGV, Meritz Securities, & IBK
This post looks into the upcoming lockup releases among the KOSPI-listed stocks and examines those included in the KOSPI 200 for short-selling...
369 Views
The First SRI Mutual Fund Aimed at Investing in Korean Companies that Promote Women
In the past week, Meritz Asset Management launched the "Meritz The Women Fund (메리츠더우먼펀드)," which is the first SRI Mutual Fund aimed at investing...
476 Views
Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race
Icure Pharm Inc (175250 KS) will offer a total of 1,200,000 shares (100% new rights offering) at ₩44,000 - ₩55,000 which gives a market cap of...
277 Views